WO2007143061A3 - Prednisolone salt formulations - Google Patents

Prednisolone salt formulations Download PDF

Info

Publication number
WO2007143061A3
WO2007143061A3 PCT/US2007/012883 US2007012883W WO2007143061A3 WO 2007143061 A3 WO2007143061 A3 WO 2007143061A3 US 2007012883 W US2007012883 W US 2007012883W WO 2007143061 A3 WO2007143061 A3 WO 2007143061A3
Authority
WO
WIPO (PCT)
Prior art keywords
tablets
prednisolone
salt formulations
odts
prednisolone salt
Prior art date
Application number
PCT/US2007/012883
Other languages
French (fr)
Other versions
WO2007143061A2 (en
Inventor
Walid Habib
Bhaveshkumar Kothari
Original Assignee
Cima Labs Inc
Walid Habib
Bhaveshkumar Kothari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/638,216 external-priority patent/US8637076B2/en
Priority claimed from US11/638,260 external-priority patent/US20070281014A1/en
Application filed by Cima Labs Inc, Walid Habib, Bhaveshkumar Kothari filed Critical Cima Labs Inc
Priority to CA002653480A priority Critical patent/CA2653480A1/en
Priority to MX2008015058A priority patent/MX2008015058A/en
Publication of WO2007143061A2 publication Critical patent/WO2007143061A2/en
Publication of WO2007143061A3 publication Critical patent/WO2007143061A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to tablets containing prednisolone salts and in particular prednisolone sodium phosphates. The dosage forms include ODTs and non- ODTs, effervescent tablets and noneffervescent tablets and tablets meeting certain performance criteria.
PCT/US2007/012883 2006-06-01 2007-05-31 Prednisolone salt formulations WO2007143061A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002653480A CA2653480A1 (en) 2006-06-01 2007-05-31 Prednisolone salt formulations
MX2008015058A MX2008015058A (en) 2006-06-01 2007-05-31 Prednisolone salt formulations.

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US81001506P 2006-06-01 2006-06-01
US60/810,015 2006-06-01
US11/638,216 2006-12-13
US11/638,216 US8637076B2 (en) 2006-06-01 2006-12-13 Prednisolone salt formulations
US11/638,260 US20070281014A1 (en) 2006-06-01 2006-12-13 Prednisolone salt formulations
US11/638,260 2006-12-13

Publications (2)

Publication Number Publication Date
WO2007143061A2 WO2007143061A2 (en) 2007-12-13
WO2007143061A3 true WO2007143061A3 (en) 2008-02-14

Family

ID=38616310

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2007/013008 WO2007143131A2 (en) 2006-06-01 2007-05-30 Prednisolone sodium phosphate formulations
PCT/US2007/012883 WO2007143061A2 (en) 2006-06-01 2007-05-31 Prednisolone salt formulations

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2007/013008 WO2007143131A2 (en) 2006-06-01 2007-05-30 Prednisolone sodium phosphate formulations

Country Status (3)

Country Link
CA (2) CA2653485A1 (en)
MX (2) MX2008015059A (en)
WO (2) WO2007143131A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926722B1 (en) * 2008-01-25 2010-09-03 Substipharm Dev APPROPRIATE PHARMACEUTICAL FORMULATION FOR THE PREPARATION OF ORODISPERSIBLE PRELOISOLONE TABLETS

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615854A (en) *
WO2000030617A1 (en) * 1998-11-25 2000-06-02 Cima Labs Inc. Taste masking rapid release coating system
WO2003053415A1 (en) * 2001-12-20 2003-07-03 Alpex Pharma Sa Pharmaceutical composition comprising skim milk powder
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
WO2004060354A1 (en) * 2002-12-31 2004-07-22 Augsburger Larry L Methods for making pharmaceutical dosage forms containing active cushioning components
US20050287211A1 (en) * 2004-04-30 2005-12-29 Astellas Pharma Inc. Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615854A (en) *
WO2000030617A1 (en) * 1998-11-25 2000-06-02 Cima Labs Inc. Taste masking rapid release coating system
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
WO2003053415A1 (en) * 2001-12-20 2003-07-03 Alpex Pharma Sa Pharmaceutical composition comprising skim milk powder
WO2004060354A1 (en) * 2002-12-31 2004-07-22 Augsburger Larry L Methods for making pharmaceutical dosage forms containing active cushioning components
US20050287211A1 (en) * 2004-04-30 2005-12-29 Astellas Pharma Inc. Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition

Also Published As

Publication number Publication date
WO2007143131A3 (en) 2008-03-20
CA2653485A1 (en) 2007-12-13
WO2007143131A2 (en) 2007-12-13
WO2007143131A9 (en) 2008-02-14
CA2653480A1 (en) 2007-12-13
MX2008015058A (en) 2009-04-14
MX2008015059A (en) 2009-04-14
WO2007143061A2 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
HUP0600027A3 (en) Antiseptic compositions, methods and systems
IL232447A0 (en) Local topical administration formulations containing indoxacarb
TWI345985B (en) Mild, moisturizing cleansing compositions
EP1730163A4 (en) Pharmaceuticals salts of 3-o-(3,3-dimethylsuccinyl) betulinic acid
GB0415219D0 (en) Improvements in or relating to time-of-flight ranging systems
WO2006131591A3 (en) An entacapone-containing oral dosage form
IL189737A0 (en) Pyrazine derivatives, their preparation and pharmaceutical compositions containing them
GB0404857D0 (en) Improvements in or relating to time-of-flight ranging systems
WO2010030598A3 (en) Pharmaceutical formulations comprising pemetrexed
PT2076244T (en) Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof
IL195528A (en) Pyridazine compound, methods for its preparation, pharmaceutical composition comprising the same, use thereof and intermediate
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
EP1916251A4 (en) Erianin salts, their preparation methods and pharmaceutical compositions containing the same
IL195813A0 (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
WO2007002823A3 (en) Formulations of conjugated estrogens and bazedoxifene
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
HK1121955A1 (en) Lotion preparation containing pyridonecarboxylic acid derivative
GB0502787D0 (en) Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
WO2008003050A3 (en) Gallium nitrate formulations
WO2004073686A3 (en) Menthol solutions of drugs
WO2007098924A3 (en) Composition comprising an agent for stabilizing active substances in drinking water, effervescent mixture, method for the production thereof, and use thereof
WO2007143061A3 (en) Prednisolone salt formulations
IL190063A (en) Substituted cycloalkene derivatives, pharmaceutical compositions containing the same and uses thereof
WO2008015202A3 (en) Anticonvulsive pharmaceutical compositions
WO2007116297A3 (en) Use of aminapthone for the preparation of a medicament for treating arteriophaties

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07795566

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2653480

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/A/2008/015058

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07795566

Country of ref document: EP

Kind code of ref document: A2